MAGT1 and central nervous system cancer: Also, by indicating the involvement of the MAGT1/ERK/MAPK axis in radioresistance of glioma cells, this study provides potential adjuvant therapies for enhancing the efficacy of radiotherapy in clinical treatment for glioma.